| P50 | author | Knud Juel | Q37607717 |
| | Esben Meulengracht Flachs | Q41600244 |
| | Marie Bak | Q58490156 |
| | Nina Rottmann | Q83393869 |
| P2093 | author name string | Ann-Dorthe Zwisler | |
| | Anne Illemann Christensen | |
| | Hans Carl Hasselbalch | |
| | Christen Lykkegaard Andersen | |
| | Nana Brochmann | |
| P2860 | cites work | The Danish National Patient Registry: a review of content, data quality, and research potential | Q26775834 |
| | Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis | Q27853043 |
| | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia | Q27853375 |
| | The hospital anxiety and depression scale | Q27860968 |
| | Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis | Q28292593 |
| | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| | The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 |
| | Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey | Q35938283 |
| | Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study | Q36157668 |
| | The myeloproliferative disorders | Q36675917 |
| | Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs | Q36915139 |
| | Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey | Q37631854 |
| | A nationwide population-based cross-sectional survey of health-related quality of life in patients with myeloproliferative neoplasms in Denmark (MPNhealthSurvey): survey design and characteristics of respondents and nonrespondents | Q37682689 |
| | The Danish Civil Registration System as a tool in epidemiology | Q38223251 |
| | Therapy for myeloproliferative neoplasms: when, which agent, and how? | Q38282813 |
| | Danish nationwide registers for public health and health-related research | Q38373247 |
| | The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group | Q39857628 |
| | The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer | Q40144016 |
| | Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms | Q40257930 |
| | Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls | Q40795436 |
| | Comprehensively understanding fatigue in patients with myeloproliferative neoplasms. | Q41048116 |
| | Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study | Q42106259 |
| | Comparison of assessment methods for self-reported alcohol consumption in health interview surveys | Q42615244 |
| | The Danish National Health Survey 2010. Study design and respondent characteristics | Q44469712 |
| | Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies | Q46324032 |
| | Validation of a self-administered modified CAGE test (CAGE-C) in a somatic hospital ward: comparison with biochemical markers. | Q46792184 |
| | Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms | Q47363691 |
| | The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients | Q48680927 |
| | Comparison of the Danish Physical Activity Questionnaire with a validated position and motion instrument. | Q50546832 |
| | The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. | Q51161824 |
| | The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory | Q74635584 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Denmark | Q35 |
| P304 | page(s) | 23-33 | |
| P577 | publication date | 2018-12-18 | |
| P1433 | published in | Clinical Epidemiology | Q5133758 |
| P1476 | title | Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark | |
| P478 | volume | 11 | |